These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22666399)

  • 1. Tumor necrosis factor-α induced protein 8 polymorphism and risk of non-Hodgkin's lymphoma in a Chinese population: a case-control study.
    Zhang Y; Wang MY; He J; Wang JC; Yang YJ; Jin L; Chen ZY; Ma XJ; Sun MH; Xia KQ; Hong XN; Wei QY; Zhou XY
    PLoS One; 2012; 7(5):e37846. PubMed ID: 22666399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.
    Zhang Y; Chen MB; Zhou XY; Hong XN
    PLoS One; 2013; 8(6):e66411. PubMed ID: 23840460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
    Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LTA, LEP, and TNF-a Gene Polymorphisms are Associated with Susceptibility and Overall Survival of Diffuse Large B-Cell lymphoma in an Arab Population: A Case-Control Study.
    Al-Khatib SM; Abdo N; Al-Eitan LN; Al-Mistarehi AW; Zahran DJ; Kewan TZ
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2783-2791. PubMed ID: 32986381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.
    Wang SS; Cozen W; Cerhan JR; Colt JS; Morton LM; Engels EA; Davis S; Severson RK; Rothman N; Chanock SJ; Hartge P
    Cancer Res; 2007 May; 67(10):5042-54. PubMed ID: 17510437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
    Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
    PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of XRCC1 genetic polymorphism with susceptibility to non-Hodgkin's lymphoma].
    Li SX; Zhu HL; Guo B; Yang Y; Wang HY; Sun JF; Cao YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):982-7. PubMed ID: 25130814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis.
    Lin HY; Shi H; Li CY; Chen QC; Huang TB; Liu PC; Lou LM
    J BUON; 2015; 20(1):261-8. PubMed ID: 25778326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between genetic variants in immunoregulatory genes and risk of non-Hodgkin lymphoma in a Chinese population.
    Ye X; Zhao K; Wu C; Hu P; Fu H
    Oncotarget; 2017 Feb; 8(6):10450-10457. PubMed ID: 28060727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk.
    Wang SS; Purdue MP; Cerhan JR; Zheng T; Menashe I; Armstrong BK; Lan Q; Hartge P; Kricker A; Zhang Y; Morton LM; Vajdic CM; Holford TR; Severson RK; Grulich A; Leaderer BP; Davis S; Cozen W; Yeager M; Chanock SJ; Chatterjee N; Rothman N
    PLoS One; 2009; 4(4):e5360. PubMed ID: 19390683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
    Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
    Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.
    Skibola CF; Bracci PM; Nieters A; Brooks-Wilson A; de Sanjosé S; Hughes AM; Cerhan JR; Skibola DR; Purdue M; Kane E; Lan Q; Foretova L; Schenk M; Spinelli JJ; Slager SL; De Roos AJ; Smith MT; Roman E; Cozen W; Boffetta P; Kricker A; Zheng T; Lightfoot T; Cocco P; Benavente Y; Zhang Y; Hartge P; Linet MS; Becker N; Brennan P; Zhang L; Armstrong B; Smith A; Shiao R; Novak AJ; Maynadie M; Chanock SJ; Staines A; Holford TR; Holly EA; Rothman N; Wang SS
    Am J Epidemiol; 2010 Feb; 171(3):267-76. PubMed ID: 20047977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity and non-Hodgkin's lymphoma (NHL) related genes in a nested case-control study for gastric cancer risk.
    Park SK; Yang JJ; Oh S; Cho LY; Ma SH; Shin A; Ko KP; Park T; Yoo KY; Kang D
    PLoS One; 2012; 7(9):e45274. PubMed ID: 23028900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in DNA repair genes and risk of non-Hodgkin's lymphoma in New South Wales, Australia.
    Shen M; Purdue MP; Kricker A; Lan Q; Grulich AE; Vajdic CM; Turner J; Whitby D; Chanock S; Rothman N; Armstrong BK
    Haematologica; 2007 Sep; 92(9):1180-5. PubMed ID: 17666372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.
    Kelly JL; Novak AJ; Fredericksen ZS; Liebow M; Ansell SM; Dogan A; Wang AH; Witzig TE; Call TG; Kay NE; Habermann TM; Slager SL; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2847-58. PubMed ID: 20855536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
    Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
    Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis of genetic variants in the ghrelin and tumor necrosis factor α genes and the risk for non-Hodgkin's lymphoma in Kuwaitis.
    Alrashid MH; Al-Serri A; Alshemmari SH; Geo JA; Al-Bustan SA
    Cancer Biomark; 2021; 32(1):11-18. PubMed ID: 34024815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.
    Morton LM; Purdue MP; Zheng T; Wang SS; Armstrong B; Zhang Y; Menashe I; Chatterjee N; Davis S; Lan Q; Vajdic CM; Severson RK; Holford TR; Kricker A; Cerhan JR; Leaderer B; Grulich A; Yeager M; Cozen W; Hoar Zahm S; Chanock SJ; Rothman N; Hartge P
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1259-70. PubMed ID: 19336552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of genome-wide association study-identified genetic variants for non-Hodgkin lymphoma in a Chinese population.
    Qiao Y; Zhou Y; Wu C; Zhai K; Han X; Chen J; Tian X; Chang J; Lu Z; Zhang B; Yu D; Yao J; Shi Y; Tan W; Lin D
    Carcinogenesis; 2013 Jul; 34(7):1516-9. PubMed ID: 23455380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.